Invitrogen

CD11c Monoclonal Antibody (N418), Super Bright™ 600, eBioscience™

Product Image Gallery

CD11c Antibody in Flow Cytometry (Flow) — C57BL/6 mouse splenocytes were stained with CD45R (B220) Monoclonal Antibody, FITC (Product # 11-0452-82) and 0.06 µg of Armenian Hamster IgG Isotype Control, Super Bright 600 (Product # 63-4888-82) (left) or 0.06 µg of CD11c Monoclonal Antibody, Super Bright 600 (right). Total viable cells were used for analysis.

CD11c Antibody in Immunocytochemistry (ICC/IF) — FLCs are different from macrophages. (A) Cell morphology of mouse FLCs at passage 2 (right panel) and macrophage cell line Raw 264.7 (left panel). (B) FLCs at passage 1 and Raw264.7 were stained with either CD11b or CD11c or CD14 antibody. Scale bars, 50 mum.

CD11c Antibody in Immunohistochemistry (IHC) — Figure 6 Glufosinate treatment promotes M1-like TAMs, CTL tumor accumulation, vessel pruning, and normalization and inhibits metastasis in a murine model of melanoma A Experimental plan. Mice were intradermally injected with YUMM 1.7 (CD90.1 + ) cells. When the tumor reached 80-100 mm 3 size, mice were treated by gavage with glufosinate (20 mg/kg) or vehicle for 14 days. B, C Intradermal YUMM 1.7 (CD90.1 + ) tumor growth over the time (B) and number of metastatic lesions per lung (C) in vehicle and glufosinate (20 mg/kg)-treated mice (pool of 2 independent experiments; 10 mice per condition in total). D Representative images of metastatic lesions checked by DAB-H stain for CD90.1 positivity in vehicle and glufosinate (20 mg/kg)-treated mice ( n = 6). Six images per lung were analyzed. Scale bar: 2 mm. Zoomed area scale bar: 50 mum. E, F FACS quantification of M1-like MHC class II high (E) and MHC class II low (F) CD11c + CD206 - TAMs over the total number of F4/80 + cells in vehicle and glufosinate (20 mg/kg)-treated mice ( n = 6). G Quantification and representative images of CD11c + cells over the total number of F4/80 + cells in vehicle and glufosinate (20 mg/kg)-treated mice ( n = 6). Six images per tumor were analyzed. Scale bars: 50 mum. H, I FACS quantification of M2-like MHC class II high (H) and MHC class II low (I) CD11c - CD206 + TAMs over the total number of F4/80 + cells in vehicle and glufosinate (20 mg/kg)-treated mice ( n = 6). J Quantification and representat

CD11c Antibody in Immunohistochemistry, Flow Cytometry (IHC, Flow) — Glufosinate treatment promotes M1-like TAMs, CTL tumor accumulation, vessel pruning, and normalization and inhibits metastasis in a murine model of melanoma A Experimental plan. Mice were intradermally injected with YUMM 1.7 (CD90.1 + ) cells. When the tumor reached 80-100 mm 3 size, mice were treated by gavage with glufosinate (20 mg/kg) or vehicle for 14 days. B, C Intradermal YUMM 1.7 (CD90.1 + ) tumor growth over the time (B) and number of metastatic lesions per lung (C) in vehicle and glufosinate (20 mg/kg)-treated mice (pool of 2 independent experiments; 10 mice per condition in total). D Representative images of metastatic lesions checked by DAB-H stain for CD90.1 positivity in vehicle and glufosinate (20 mg/kg)-treated mice ( n = 6). Six images per lung were analyzed. Scale bar: 2 mm. Zoomed area scale bar: 50 mum. E, F FACS quantification of M1-like MHC class II high (E) and MHC class II low (F) CD11c + CD206 - TAMs over the total number of F4/80 + cells in vehicle and glufosinate (20 mg/kg)-treated mice ( n = 6). G Quantification and representative images of CD11c + cells over the total number of F4/80 + cells in vehicle and glufosinate (20 mg/kg)-treated mice ( n = 6). Six images per tumor were analyzed. Scale bars: 50 mum. H, I FACS quantification of M2-like MHC class II high (H) and MHC class II low (I) CD11c - CD206 + TAMs over the total number of F4/80 + cells in vehicle and glufosinate (20 mg/kg)-treated mice ( n = 6). J Quantification and representative image

Product Details

63-0114-82

Applications	Tested Dilution	Publications
Immunohistochemistry (IHC)	-	View 1 publication 1 publication
Immunocytochemistry (ICC/IF)	-	View 2 publications 2 publications
Flow Cytometry (Flow)	0.125 µg/test	View 10 publications 10 publications

Product Specifications
Species Reactivity	Mouse
Published species	Not Applicable
Host/Isotype	Armenian hamster / IgG
Recommended Isotype Control	Armenian Hamster IgG Isotype Control (eBio299Arm), Super Bright™ 600, eBioscience™
Class	Monoclonal
Type	Antibody
Clone	N418
Conjugate	Super Bright™ 600 Alexa Fluor 488 Alexa Fluor 532 Alexa Fluor 660 Alexa Fluor 700 APC APC-eFluor 780 Biotin Brilliant UV 737 Brilliant UV 805 eFluor 450 eFluor 506 eFluor 615 eFluor 660 FITC Functional Grade NovaFluor Blue 510 NovaFluor Blue 610-30S NovaFluor Blue 660-40S NovaFluor Yellow 570 PE PE-Cyanine5 PE-Cyanine5.5 PE-Cyanine7 PE-eFluor 610 PerCP-Cyanine5.5 Super Bright
Excitation/Emission Profile	View spectra
Form	Liquid
Concentration	0.2 mg/mL
Purification	Affinity chromatography
Storage buffer	PBS, pH 7.2, with BSA
Contains	0.09% sodium azide
Storage conditions	4° C, store in dark, DO NOT FREEZE!
RRID	AB_2722930

Product Specific Information

Description: The N418 monoclonal antibody reacts with mouse CD11c, the integrin alphaX. CD11c non-covalently associates with beta2 integrin to form the CD11c/CD18 heterodimer. CD11c is expressed by dendritic cells, a subset of Intestinal Intraepithelial Lymphocytes (IEL) and some activated T cells. CD11c/CD18 binds to CD54, iC3b and fibrinogen and plays a role in leukocyte adhesive interactions. N418 binds to CD11c on splenic dendritic cells in the T-dependent areas of mouse spleen and precipitates a 150, 90 kDa heterodimer.

Applications Reported: This N418 antibody has been reported for use in flow cytometric analysis.

Applications Tested: This N418 antibody has been tested by flow cytometric analysis of mouse splenocytes. This may be used at less than or equal to 0.125 µg per test. A test is defined as the amount (µg) of antibody that will stain a cell sample in a final volume of 100 µL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.

Super Bright 600 is a tandem dye that can be excited with the violet laser line (405 nm) and emits at 600 nm. We recommend using a 610/20 bandpass filter. Please make sure that your instrument is capable of detecting this fluorochrome.

When using two or more Super Bright dye-conjugated antibodies in a staining panel, it is recommended to use Super Bright Complete Staining Buffer (Product # SB-4401) to minimize any non-specific polymer interactions. Please refer to the datasheet for Super Bright Staining Buffer for more information.

Light sensitivity: This tandem dye is sensitive to photo-induced oxidation. Please protect this vial and stained samples from light.

Fixation: Samples can be stored in IC Fixation Buffer (Product # 00-8222) (100 µL of cell sample + 100 µL of IC Fixation Buffer) or 1-step Fix/Lyse Solution (Product # 00-5333) for up to 3 days in the dark at 4°C with minimal impact on brightness and FRET efficiency/compensation. Some generalizations regarding fluorophore performance after fixation can be made, but clone specific performance should be determined empirically.

Excitation: 405 nm; Emission: 600 nm; Laser: Violet Laser

Super Bright Polymer Dyes are sold under license from Becton, Dickinson and Company.

Target Information

CD11, along with CD18, form a heterodimer adhesion molecule. In particular, CD11 is composed of CD11a, CD11b and CD11c. CD11a is a leukocyte marker that is expressed in B and T lymphocytes, macrophages, monocytes, neutrophils, basophils and eosinophils. CD11b is primarily expressed by monocytes, macrophages, natural killer cells, some B and T-cells, and granulocytes. CD11c is expressed in monocytes, macrophages, natural killer cells, some granulocytes and less so in a subset of lymphocytes.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Flow Cytometry

Panel Builder

How to use the Panel Builder

Watch the video to learn how to use the Invitrogen Flow Cytometry Panel Builder to build your next flow cytometry panel in 5 easy steps.

Product References

CNS Immune Profiling in a Dengue Virus-Infected Immunocompetent Outbred ICR Mice Strain.

Frontiers in cellular and infection microbiology

Shen TJ,Chen CL,Jhan MK,Tseng PC,Lin CF

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Thu Jun 17 00:00:00 EDT 2021

Analysis of the immune response to sciatic nerve injury identifies efferocytosis as a key mechanism of nerve debridement.

eLife

Kalinski AL,Yoon C,Huffman LD,Duncker PC,Kohen R,Passino R,Hafner H,Johnson C,Kawaguchi R,Carbajal KS,Jara JS,Hollis E,Geschwind DH,Segal BM,Giger RJ

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Wed Dec 02 00:00:00 EST 2020

CD103⁺ cDC1 and endogenous CD8⁺ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function.

Nature communications

Kuhn NF,Lopez AV,Li X,Cai W,Daniyan AF,Brentjens RJ

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Wed Dec 02 00:00:00 EST 2020

Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages.

EMBO molecular medicine

Menga A,Serra M,Todisco S,Riera-Domingo C,Ammarah U,Ehling M,Palmieri EM,Di Noia MA,Gissi R,Favia M,Pierri CL,Porporato PE,Castegna A,Mazzone M

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Immunohistochemistry

Wed Oct 07 00:00:00 EDT 2020

Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages.

EMBO molecular medicine

Menga A,Serra M,Todisco S,Riera-Domingo C,Ammarah U,Ehling M,Palmieri EM,Di Noia MA,Gissi R,Favia M,Pierri CL,Porporato PE,Castegna A,Mazzone M

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Immunohistochemistry

Wed Oct 07 00:00:00 EDT 2020

Mycobacterium tuberculosis-infected alveolar epithelial cells modulate dendritic cell function through the HIF-1α-NOS2 axis.

Journal of leukocyte biology

Rodrigues TS,Alvarez ARP,Gembre AF,Forni MFPAD,de Melo BMS,Alves Filho JCF,Câmara NOS,Bonato VLD

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Thu Oct 01 00:00:00 EDT 2020

Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target.

JCI insight

Pierini S,Tanyi JL,Simpkins F,George E,Uribe-Herranz M,Drapkin R,Burger R,Morgan MA,Facciabene A

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Thu Aug 20 00:00:00 EDT 2020

Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis.

Scientific reports

Monteran L,Ershaid N,Sabah I,Fahoum I,Zait Y,Shani O,Cohen N,Eldar-Boock A,Satchi-Fainaro R,Erez N

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Fri Aug 14 00:00:00 EDT 2020

Suppression of Inflammasome Activation by IRF8 and IRF4 in cDCs Is Critical for T Cell Priming.

Cell reports

McDaniel MM,Kottyan LC,Singh H,Pasare C

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Tue May 05 00:00:00 EDT 2020

Diversity in medullary thymic epithelial cells controls the activity and availability of iNKT cells.

Nature communications

Lucas B,White AJ,Cosway EJ,Parnell SM,James KD,Jones ND,Ohigashi I,Takahama Y,Jenkinson WE,Anderson G

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Mon May 04 00:00:00 EDT 2020

Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population.

Cell reports

Leylek R,Alcántara-Hernández M,Lanzar Z,Lüdtke A,Perez OA,Reizis B,Idoyaga J

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Flow Cytometry

Tue Dec 10 00:00:00 EST 2019

Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor.

Journal of cellular physiology

Li Y,Adomat H,Guns ET,Hojabrpour P,Duronio V,Curran TA,Jalili RB,Jia W,Delwar Z,Zhang Y,Elizei SS,Ghahary A

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Immunocytochemistry

Wed Jun 01 00:00:00 EDT 2016

Leptin receptor is expressed in thymus medulla and leptin protects against thymic remodeling during endotoxemia-induced thymus involution.

The Journal of endocrinology

Gruver AL,Ventevogel MS,Sempowski GD

Published figure using CD11c monoclonal antibody (Product # 63-0114-82) in Immunocytochemistry

Thu Oct 01 00:00:00 EDT 2009

Bioinformatics

Protein Aliases: CD11 antigen-like family member C; CD11c; CD11C (p150) alpha polypeptide; complement receptor 4; Integrin alpha-X; integrin aX; Leukocyte adhesion glycoprotein p150,95 alpha chain; Leukocyte adhesion receptor p150,95

Gene Aliases: AI449405; Cd11c; Cr4; Itgax; N418

UniProt ID: (Mouse) Q9QXH4

Entrez Gene ID: (Mouse) 16411

Molecular Function: integrin